Lexeo Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-55.6M | $135.9M |
| FY2022 | — | $-113.0M | $77.3M |
| FY2023 | — | $113.5M | $121.5M |
| FY2024 | — | $116.8M | $35.0M |
| FY2025 | — | $246.7M | $63.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-55.6M | $135.9M |
| FY2022 | — | $-113.0M | $77.3M |
| FY2023 | — | $113.5M | $121.5M |
| FY2024 | — | $116.8M | $35.0M |
| FY2025 | — | $246.7M | $63.0M |